These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 15981806

  • 1. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA.
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [Abstract] [Full Text] [Related]

  • 2. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, Casasnovas O, Vergier B, Teitell MA.
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [Abstract] [Full Text] [Related]

  • 3. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S, Massone C, Ferrara G, Rongioletti F, Papini M, Pileri S, Cerroni L.
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [Abstract] [Full Text] [Related]

  • 4. CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
    Weaver J, Hsi ED.
    J Cutan Pathol; 2008 Oct; 35(10):975-7. PubMed ID: 18822062
    [No Abstract] [Full Text] [Related]

  • 5. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS.
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [Abstract] [Full Text] [Related]

  • 6. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA.
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN.
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [Abstract] [Full Text] [Related]

  • 8. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M, Jones D.
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [Abstract] [Full Text] [Related]

  • 9. [Hematodermic CD4/CD56 neoplasm].
    Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, Déchelotte P, Feuillard J, Durlach A, Vergier B.
    Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [Abstract] [Full Text] [Related]

  • 10. CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both?
    McNiff JM, Cowper SE, Lazova R, Subtil A, Glusac EJ.
    J Cutan Pathol; 2005 Sep; 32(8):541-5. PubMed ID: 16115052
    [Abstract] [Full Text] [Related]

  • 11. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
    Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D.
    Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
    [Abstract] [Full Text] [Related]

  • 12. Fine-needle aspiration cytology of blastic natural killer-cell lymphoma (CD4+ CD56+ hematodermic neoplasm).
    Wu HH, Ren R, Roepke JE.
    Diagn Cytopathol; 2004 Apr; 30(4):268-70. PubMed ID: 15048964
    [Abstract] [Full Text] [Related]

  • 13. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
    Ruggiero A, Maurizi P, Larocca LM, Arlotta A, Riccardi R.
    Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
    [Abstract] [Full Text] [Related]

  • 14. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
    Hallermann C, Middel P, Griesinger F, Gunawan B, Bertsch HP, Neumann C.
    Eur J Dermatol; 2004 Dec; 14(5):317-22. PubMed ID: 15358570
    [Abstract] [Full Text] [Related]

  • 15. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M, Marchione R, Ricotti C, Romanelli P, Alonso-Llamazares J.
    Dermatol Online J; 2008 Nov 15; 14(11):5. PubMed ID: 19094843
    [Abstract] [Full Text] [Related]

  • 16. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, Dummer R.
    Hum Pathol; 2005 Sep 15; 36(9):1020-4. PubMed ID: 16153467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY, McFarlane R, Kalus A, Olerud J, Cherian S, Fromm J, George E, Argenyi Z.
    J Cutan Pathol; 2008 Jun 15; 35(6):579-84. PubMed ID: 18005171
    [Abstract] [Full Text] [Related]

  • 19. CD4(+)/CD56(+) hematodermic neoplasm.
    Carlesimo M, Mari E, Cortesi G, Orsini D, Narcisi A, Cox MC, Ruco L, Pulcini F, Camplone G.
    Eur J Dermatol; 2011 Jun 15; 21(2):291-2. PubMed ID: 21382786
    [No Abstract] [Full Text] [Related]

  • 20. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature.
    Eguaras AV, Lo RW, Veloso JD, Tan VG, Enriquez ML, Del Rosario ML.
    J Pediatr Hematol Oncol; 2007 Nov 15; 29(11):766-9. PubMed ID: 17984695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.